ArticleCancer biotherapy & radiopharmaceuticals2011

In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma.

Beau Ballard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.